Table 2.
Demographic characteristics of 279 medical cannabis patients, by symptom group
| Sample size (percentage) | Number of female patients (percentage) | Mean age (SD) | |
|---|---|---|---|
| Overall sample | 279 | 190 (68) | 61.1 (16.6) |
| Moderate or severe pain symptom group | 205 (73.5) | 150 (73) | 61.8 (15.9) |
| Moderate or severe anxiety symptom group | 138 (48.5) | 97 (70) | 61.43 (16.3) |
| Moderate or severe depression symptom group | 115 (41.2) | 81 (70) | 60.5 (15) |
| Moderate or severe wellbeing group | 202 (72.4) | 141 (70) | 60.8 (16.1) |
| CBD/THC:CBD group | 116 (41.6) | 75 (65) | 60.38 (14.4) |
The symptom groups are mild and moderate or severe. The table presents the moderate or severe demographic characteristics. The CBD/THC:CBD group is composed of patients who added THC to their CBD-rich prescription during FUP1
CBD cannabidiol, THC Δ9-tetrahydrocannabinol, SD standard deviation